GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Other Operating Expense

Surgical Innovations Group (LSE:SUN) Other Operating Expense : £4.33 Mil (TTM As of Jun. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Other Operating Expense?

Surgical Innovations Group's Other Operating Expense for the six months ended in Jun. 2024 was £2.47 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was £4.33 Mil.

Surgical Innovations Group's quarterly Other Operating Expense declined from Jun. 2023 (£2.17 Mil) to Dec. 2023 (£1.87 Mil) but then increased from Dec. 2023 (£1.87 Mil) to Jun. 2024 (£2.47 Mil).

Surgical Innovations Group's annual Other Operating Expense declined from Dec. 2021 (£0.29 Mil) to Dec. 2022 (£0.27 Mil) but then increased from Dec. 2022 (£0.27 Mil) to Dec. 2023 (£0.31 Mil).


Surgical Innovations Group Other Operating Expense Historical Data

The historical data trend for Surgical Innovations Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Other Operating Expense Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.53 0.29 0.27 0.31

Surgical Innovations Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.93 1.92 2.17 1.87 2.47

Surgical Innovations Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £4.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Surgical Innovations Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and equipment for precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment which derives key revenue, includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The Distribution segment includes the distribution of specialist medical products.